Pericyte NNMT drives an immune-hostile vascular niche and restricts cancer immunotherapy.
Wang S, Ye G, Zhang C, Tan L, Zhang Z, Xu X, Chen X, Zhang Y, Xu X, Pan J, Lan T, Zhang J, Lin C, Huang D, Li X, Yuan X, Chen M, Wang C, Ye W, Zhang D, Huang M.
Wang S, et al. Among authors: zhang c, zhang d, zhang z, zhang j, zhang y.
Sci Bull (Beijing). 2026 Apr 30;71(8):1912-1916. doi: 10.1016/j.scib.2026.02.001. Epub 2026 Feb 5.
Sci Bull (Beijing). 2026.
PMID: 41714234
No abstract available.